Peptide research, explained.
Detailed guides to peptide identity, biological pathways, analytical methods and clinical evidence. Search the reading room or follow a research topic.
Browse 13 research topics
All guides & articles
Research PracticeWeight Regain After Stopping Semaglutide: What STEP Studied
The often-quoted claim that people regain two-thirds of their weight loss after stopping semaglutide comes from a particular follow-up study.
Updated 2026-10-29 ↗
Peptide FundamentalsSetmelanotide: MC4 Signaling and Specific Obesity Conditions
Setmelanotide is an MC4-receptor agonist with a clinical record tied to specified causes and contexts of obesity.
Updated 2026-10-29 ↗
Research PracticeSkin-Care Peptides: Copper Complexes, Signal Peptides and Evidence
A skin-care peptide claim is strongest when it points to the tested finished formulation and a defined skin outcome.
Updated 2026-10-29 ↗
Peptide FundamentalsTeduglutide and GLP-2: Evidence in Short Bowel Syndrome
Teduglutide is a GLP-2 analogue whose clinical record concerns short bowel syndrome with dependence on parenteral support.
Updated 2026-10-29 ↗
Research PracticeTirzepatide in HFpEF: What SUMMIT Adds Beyond Weight Loss
SUMMIT studied tirzepatide in people with obesity and heart failure with preserved ejection fraction.
Updated 2026-10-29 ↗
Research PracticeTirzepatide and MASH: What SYNERGY-NASH Can Establish
A liver-enzyme improvement, a reduction in liver fat and a change in biopsy-defined MASH describe different findings.
Updated 2026-10-29 ↗
Research PracticeTirzepatide and Sleep Apnea: What SURMOUNT-OSA Measured
Tirzepatide sleep-apnea research is strongest when the breathing measurement stays attached to the result.
Updated 2026-10-29 ↗
Research PracticeVK2735: Reading VENTURE and the Oral Research Separately
VK2735 has been studied as an injected and an oral GIP/GLP-1 receptor agonist, but the two research records should not be fused into one result.
Updated 2026-10-29 ↗
Peptide FundamentalsVosoritide: CNP Signaling, Growth Velocity and Achondroplasia
Vosoritide is a C-type natriuretic peptide analogue studied for achondroplasia. Its evidence concerns growth-plate biology and growth velocity in an eligible pediatric population, not a general height-enhancement claim.
Updated 2026-10-29 ↗Ziconotide: A Conopeptide with a Very Specific Clinical Role
Ziconotide is a conopeptide medicine with a highly specific pain-management setting and route. Its N-type calcium-channel binding helps explain the research rationale, but the product record also contains substantial safety restrictions.
Updated 2026-10-29 ↗
Peptide FundamentalsGHRH vs GHRP: Understanding Growth Hormone Peptides
GHRH-related peptides and GHRP-related secretagogues can both appear in growth-hormone research, but they are not one interchangeable group.
Updated 2026-10-29 ↗
Peptide FundamentalsGLP-1, GIP, Glucagon and Amylin Peptides Compared
GLP-1, GIP, glucagon and amylin name different signaling systems, not four interchangeable versions of one weight-loss peptide.
Updated 2026-10-29 ↗